Spectral AI, Inc. (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced that Stanley Micek has been named the Company’s Chief Operating Officer (“COO”). Micek’s promotion reflects his role change from Interim COO of the Company since May, 2024
AI Authority Trend: Spectral AI Secures up to $15 Million Debt Financing to Boost U.S. Commercialization
“Stan has demonstrated exceptional leadership, operational insight, and a deep understanding of our business during his time as interim COO,” said Dr. J. Michael DiMaio, M.D., Chairman of the Company’s Board of Directors. “His efforts leading our Research and Development group and his ability to drive performance, foster cross-functional collaboration, and execute on strategic priorities made it clear that he was the right person to lead our operations moving forward.”
Since assuming the interim role, Micek has overseen the data science, software, hardware, imaging and systems teams working directly on our FDA submission.
AI Authority Trend: Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
Prior to becoming interim COO, Micek was the Senior Vice President for Business Development & Strategy at MiMedx and held numerous leadership roles at The Ohio State University at the Ohio State Comprehensive Cancer, bringing over 25 years of leadership experience in healthcare and acute wound expertise.
“I’m honored to continue this journey with Spectral AI and excited to lead our operations team as we build on our momentum from our recent Pivotal Burn Study,” said Micek. “Together, we’ll strive for excellence in providing a ground-breaking wound diagnostic tool and I am excited to work to drive our submission to the FDA in the near future.”
AI Authority Trend: Strider and SCSP Report Reveals PRC’s State-Directed Push for Asymmetric AI Advantage
Source – GlobeNewswire
To share your insights, please write to us at sudipto@intentamplify.com
